Home » Impax Laboratories Confirms Patent Challenge Relating to Fenoglide
Impax Laboratories Confirms Patent Challenge Relating to Fenoglide
Impax Laboratories Thursday confirms that it has initiated a challenge of a patent listed by Shionogi Pharma, Inc. in connection with its Fenoglide (fenofibrate)
tablets, 40 and 120 mg.
Yahoo!
Yahoo!
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May